Your Daily digest for Science Daily Mind & Brain Daily Digest (Unofficial)

[Article Digests for Psychology & Social Work]

Science Daily Mind & Brain Daily Digest (Unofficial)

 

(https://www.sciencedaily.com/releases/2025/02/250220122934.htm) Blood pressure drug could be a safer alternative for treating ADHD symptoms
Feb 20th 2025, 12:29

Repurposing amlodipine, a commonly used blood pressure medicine, could help manage attention-deficit/ hyperactivity disorder (ADHD) symptoms, according to an international study.

(https://www.sciencedaily.com/releases/2025/02/250220122625.htm) Narcissists more likely to feel ostracized
Feb 20th 2025, 12:26

Narcissists feel ostracized more frequently than their less self-absorbed peers, according to researchers. This may stem not only from being shunned due to their personalities but from a tendency to misinterpret ambiguous social signals as exclusion.

(https://www.sciencedaily.com/releases/2025/02/250220122623.htm) Another way longer paternity leaves help new parents
Feb 20th 2025, 12:26

A longer paternity leave after the birth of a child can improve the co-parenting relationship between moms and dads in a key way, a new study finds. Researchers found that mothers were less likely to discourage fathers' involvement in parenting if the dads had taken more time off after their child was born.

(https://www.sciencedaily.com/releases/2025/02/250220122553.htm) Small amounts of moderate to vigorous physical activity are associated with big reductions in dementia risk
Feb 20th 2025, 12:25

A little movement could help prevent dementia, even for frail older adults, suggests a new study.

(https://www.sciencedaily.com/releases/2025/02/250220122518.htm) Continuing vs. discontinuing opioid medications prescriptions for adults with chronic pain
Feb 20th 2025, 12:25

With the goal of informing clinician practice, a new study explores the harms and benefits of continuing and of discontinuing the long-term prescription of opioid medicines to adults with chronic pain.

(https://www.sciencedaily.com/releases/2025/02/250220122515.htm) Study suggests new molecular strategy for treating fragile X syndrome
Feb 20th 2025, 12:25

A new study shows that enhancing activity of a specific component of 'NMDA' receptors normalizes protein synthesis, neural activity and seizure susceptibility in the hippocampus of fragile X lab mice.

(https://www.sciencedaily.com/releases/2025/02/250219190824.htm) Promising results from first prenatal therapy for spinal muscular atrophy
Feb 19th 2025, 19:08

Scientists report results from a promising new approach to treat the rare neurodegenerative disorder.

(https://www.sciencedaily.com/releases/2025/02/250219154615.htm) Study reveals activity of navtemadlin in glioblastoma, points to possible treatment improvements
Feb 19th 2025, 15:46

Clinical research suggests that combining a novel agent called navtemadlin with DNA-damaging chemotherapy for the treatment of glioblastoma, a form of brain cancer, could increase efficacy. Navtemadlin is an MDM2 inhibitor that can help to kill cancer cells by boosting the activity of p53, a protein that controls cell growth and induces cell death in response to DNA damage. In lab experiments, the researchers found that navtemadlin was one of the best drugs at killing glioblastoma cells with intact, non-mutant p53.

Forwarded by:
Michael Reeder LCPC
Baltimore, MD

This information is taken from free public RSS feeds published by each organization for the purpose of public distribution. Readers are linked back to the article content on each organization's website. This email is an unaffiliated unofficial redistribution of this freely provided content from the publishers. 

 

(#) unsubscribe from this feed
-------------- next part --------------
An HTML attachment was scrubbed...
URL: <http://lists.clinicians-exchange.org/pipermail/article-digests-clinicians-exchange.org/attachments/20250221/dc21456c/attachment.htm>